Data / Research funding / Oregon / Trace Biosciences INC
Trace Biosciences INC: 2 NIH awards ($2.1M), fiscal years 2021 to 2026
Trace Biosciences INC in Beaverton, OR is funded under 2 NIH awards ($2.1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- YGDTEJXJC9G8
- State
- Oregon
Awards
2 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| Clinical Translation of Near Infrared Nerve-Specific Fluorophores for Nerve-sparing Prostatectomy | NIH | National Cancer Institute | 2022 to 2024 | $1,748,403 | July 1, 2022 | June 30, 2025 | BARTH, CONNOR WILLIAM | reporter.nih.gov |
| Two-Color Near-Infrared Fluorescence Guided Surgery Tools Enabling Simultaneous Cancer Margin and Nerve Visualization during Head and Neck Squamous Cell Carcinoma Resection | NIH | National Cancer Institute | 2023 | $386,211 | June 23, 2023 | November 30, 2024 | BARTH, CONNOR WILLIAM | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 1 | $810,809 | 0 | $0 |
| 2023 | 1 | $386,211 | 0 | $0 |
| 2022 | 1 | $937,594 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) | PAR-27-089 | NIH | 93.395 | November 2, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-27-001 | NIH | 93.394 | November 10, 2026 | $150,000 | Same assistance listing 93.394 as 1 award here |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-27-002 | NIH | 93.394 | November 10, 2026 | $300,000 | Same assistance listing 93.394 as 1 award here |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional) | PAR-26-152 | NIH | 93.395 | November 11, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.395 | November 20, 2026 | Not listed | Same assistance listing 93.395 as 1 award here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.394 | November 24, 2026 | Not listed | Same assistance listing 93.394 as 1 award here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.395 | January 7, 2027 | $375,000 | Same assistance listing 93.395 as 1 award here |
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | PAR-25-079 | NIH | 93.395 | January 7, 2027 | $500,000 | Same assistance listing 93.395 as 1 award here |
| National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | PAR-25-081 | NIH | 93.395 | January 7, 2027 | $499,999 | Same assistance listing 93.395 as 1 award here |
| Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) | RFA-CA-27-005 | NIH | 93.395 | January 11, 2027 | $700,000 | Same assistance listing 93.395 as 1 award here |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | PAR-27-009 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) | RFA-CA-26-010 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) | RFA-CA-27-003 | NIH | 93.395 | January 25, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) | PAR-26-091 | NIH | 93.394 | February 8, 2027 | Not listed | Same assistance listing 93.394 as 1 award here |
| Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed) | RFA-CA-28-004 | NIH | 93.394 | February 11, 2027 | Not listed | Same assistance listing 93.394 as 1 award here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.395 | April 5, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.395 | April 5, 2027 | Not listed | Same assistance listing 93.395 as 1 award here |
| Implementation and Evaluation of Databases to Examine AIDS | RFA-AI-28-025 | NIH | 93.394 | May 27, 2027 | Not listed | Same assistance listing 93.394 as 1 award here |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-28-001 | NIH | 93.394 | June 4, 2027 | $150,000 | Same assistance listing 93.394 as 1 award here |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-28-002 | NIH | 93.394 | June 4, 2027 | $300,000 | Same assistance listing 93.394 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.